lysyl-aspartyl-glutamyl-leucine has been researched along with paclitaxel in 2 studies
Studies (lysyl-aspartyl-glutamyl-leucine) | Trials (lysyl-aspartyl-glutamyl-leucine) | Recent Studies (post-2010) (lysyl-aspartyl-glutamyl-leucine) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
121 | 0 | 22 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, M; Delie, F; Petignat, P; Ribaux, P | 1 |
Cohen, M; Delie, F; Petignat, P | 1 |
2 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and paclitaxel
Article | Year |
---|---|
Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer?
Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Membrane Proteins; Molecular Targeted Therapy; Nanoparticles; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Protein Sorting Signals | 2012 |
GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78.
Topics: Antibodies; Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Humans; Male; Molecular Targeted Therapy; Nanoparticles; Oligopeptides; Paclitaxel; Prostatic Neoplasms, Castration-Resistant; Protein Sorting Signals; Signal Transduction | 2013 |